Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of California, San Francisco
Atavistik Bio, Inc
Aragon Pharmaceuticals, Inc.
Janssen Research & Development, LLC
University of Oklahoma
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Pharmaceutical K.K.
Novartis
Merck Sharp & Dohme LLC
City of Hope Medical Center
University of Chicago
University of Utah
Bayer
Alessa Therapeutics Inc.
Dana-Farber Cancer Institute
Arcus Biosciences, Inc.
University of Texas Southwestern Medical Center
University of Pennsylvania
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Merck Sharp & Dohme LLC
Janssen Research & Development, LLC
Emory University
Poseida Therapeutics, Inc.
Werewolf Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
University of Utah
Amgen
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai
Novartis
Bayer
AstraZeneca
Eli Lilly and Company
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Emory University